The	O
role	O
of	O
Stat4	B-protein
in	O
species-specific	O
regulation	O
of	O
Th	O
cell	O
development	O
by	O
type	B-protein
I	I-protein
IFNs	I-protein
.	O

Type	B-protein
I	I-protein
IFNs	I-protein
(	O
IFN-alpha/beta	B-protein
)	O
,	O
in	O
addition	O
to	O
IL-12	B-protein
,	O
have	O
been	O
shown	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
differentiation	O
of	O
human	O
,	O
but	O
not	O
mouse	O
,	O
Th	B-cell_type
cells	I-cell_type
.	O

We	O
show	O
here	O
that	O
IFN-alpha/beta	B-protein
act	O
directly	O
on	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
drive	O
Th1	O
development	O
,	O
bypassing	O
the	O
need	O
for	O
IL-12	B-protein
-induced	O
signaling	O
,	O
whereas	O
IFN-alpha	B-protein
can	O
not	O
substitute	O
IL-12	B-protein
for	O
mouse	O
Th1	O
development	O
.	O

The	O
molecular	O
basis	O
for	O
this	O
species	O
specificity	O
is	O
that	O
IFN-alpha/beta	B-protein
activate	O
Stat4	B-protein
in	O
differentiating	O
human	O
,	O
but	O
not	O
mouse	O
,	O
Th	B-cell_type
cells	I-cell_type
.	O

Unlike	O
IL-12	B-protein
,	O
which	O
acts	O
only	O
on	O
Th1	B-cell_type
cells	I-cell_type
,	O
IFN-alpha/beta	B-protein
can	O
activate	O
Stat4	B-protein
not	O
only	O
in	O
human	B-cell_type
Th1	I-cell_type
,	O
but	O
also	O
in	O
Th2	B-cell_type
cells	I-cell_type
.	O

However	O
,	O
restimulation	O
of	O
human	B-cell_line
Th2	I-cell_line
lines	I-cell_line
and	O
clones	O
in	O
the	O
presence	O
of	O
IFN-alpha	B-protein
does	O
not	O
induce	O
the	O
production	O
of	O
IFN-gamma	B-protein
.	O

These	O
results	O
suggest	O
that	O
activation	O
of	O
Stat4	B-protein
,	O
which	O
is	O
necessary	O
for	O
the	O
differentiation	O
of	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
into	O
polarized	O
Th1	B-cell_type
cells	I-cell_type
,	O
is	O
not	O
sufficient	O
to	O
induce	O
phenotype	O
reversal	O
of	O
human	B-cell_type
Th2	I-cell_type
cells	I-cell_type
.	O

K	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
meJournal	NULL
of	NULL
The	NULL
Role	NULL
of	NULL
Statd	NULL
in	NULL
Species-Specific	NULL
4D	NULL
Immunolo	NULL
gy	NULL
Regulation	NULL
of	NULL
Th	NULL
Cell	NULL
Development	NULL
by	NULL
Type	NULL
I	NULL
IFNs	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Lars	NULL
Rogge	NULL
,	NULL
Daniele	NULL
D'Ambrosio	NULL
,	NULL
Mauro	NULL
Biffi	NULL
,	NULL
Giuseppe	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
2151301	NULL
i	NULL
)	NULL
;	NULL
Is	NULL
current	NULL
as	NULL
Penna	NULL
,	NULL
Lisa	NULL
J.	NULL
Minetti	NULL
,	NULL
David	NULL
H.	NULL
Presky	NULL
,	NULL
Luciano	NULL
Adorini	NULL
and	NULL
Francesco	NULL
Sinigaglia	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:6567-6574	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6567	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
articles	NULL
,	NULL
24	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6567	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Role	NULL
of	NULL
Stat4	NULL
in	NULL
Species-Specific	NULL
Regulation	NULL
of	NULL
Th	NULL
Cell	NULL
Development	NULL
by	NULL
Type	NULL
I	NULL
IFNs	NULL
Lars	NULL
Rogge	NULL
,	NULL
``	NULL
*	NULL
Daniele	NULL
D'Ambrosio	NULL
,	NULL
*	NULL
Mauro	NULL
Biffi	NULL
,	NULL
*	NULL
Giuseppe	NULL
Penna	NULL
,	NULL
*	NULL
Lisa	NULL
J.	NULL
Minetti	NULL
,	NULL
'	NULL
David	NULL
H.	NULL
Presky	NULL
,	NULL
``	NULL
Luciano	NULL
Adorini	NULL
,	NULL
*®	NULL
and	NULL
Francesco	NULL
Sinigaglia*	NULL
Type	NULL
I	NULL
IFNs	NULL
(	NULL
IFN-	NULL
«	NULL
/f	NULL
)	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
IL-12	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
,	NULL
but	NULL
not	NULL
mouse	NULL
,	NULL
Th	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
IFN-	NULL
@	NULL
w/	NULL
$	NULL
B	NULL
act	NULL
directly	NULL
on	NULL
human	NULL
T	NULL
cells	NULL
to	NULL
drive	NULL
Th1	NULL
development	NULL
,	NULL
bypassing	NULL
the	NULL
need	NULL
for	NULL
IL-12-induced	NULL
signaling	NULL
,	NULL
whereas	NULL
can	NULL
not	NULL
substitute	NULL
IL-12	NULL
for	NULL
mouse	NULL
Th1	NULL
development	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
species	NULL
specificity	NULL
is	NULL
that	NULL
IFN-	NULL
@	NULL
/B	NULL
activate	NULL
Statd4	NULL
in	NULL
differentiating	NULL
human	NULL
,	NULL
but	NULL
not	NULL
mouse	NULL
,	NULL
Th	NULL
cells	NULL
.	NULL

Unlike	NULL
IL-12	NULL
,	NULL
which	NULL
acts	NULL
only	NULL
on	NULL
Th1	NULL
cells	NULL
,	NULL
IFN-	NULL
@	NULL
«	NULL
/B	NULL
can	NULL
activate	NULL
Statd4	NULL
not	NULL
only	NULL
in	NULL
human	NULL
Th1	NULL
,	NULL
but	NULL
also	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
restimulation	NULL
of	NULL
human	NULL
Th2	NULL
lines	NULL
and	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
@	NULL
does	NULL
not	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
Stat4	NULL
,	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
polarized	NULL
Th1	NULL
cells	NULL
,	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
phenotype	NULL
reversal	NULL
of	NULL
human	NULL
Th2	NULL
cells	NULL
.	NULL

differ	NULL
in	NULL
their	NULL
cytokine	NULL
secretion	NULL
pattern	NULL
and	NULL
effector	NULL
func-	NULL
tions	NULL
has	NULL
provided	NULL
a	NULL
basis	NULL
for	NULL
the	NULL
diversity	NULL
of	NULL
T	NULL
cell-de-pendent	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
two	NULL
subsets	NULL
of	NULL
differentiated	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
Thl1	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
protect	NULL
against	NULL
different	NULL
microbial	NULL
pathogens	NULL
by	NULL
producing	NULL
cytokines	NULL
able	NULL
to	NULL
mobilize	NULL
different	NULL
mechanisms	NULL
of	NULL
defense	NULL
.	NULL

Th1	NULL
cells	NULL
secrete	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
$	NULL
and	NULL
are	NULL
the	NULL
mediators	NULL
of	NULL
phagocyte-dependent	NULL
immune	NULL
reactions	NULL
,	NULL
whereas	NULL
Th2	NULL
cells	NULL
that	NULL
secrete	NULL
IL-4	NULL
and	NULL
IL-5	NULL
are	NULL
responsible	NULL
for	NULL
phagocyte-independent	NULL
host	NULL
defense	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Uncontrolled	NULL
Th1	NULL
and	NULL
Th2	NULL
responses	NULL
can	NULL
cause	NULL
chronic	NULL
inflammatory	NULL
autoimmune	NULL
diseases	NULL
and	NULL
allergies	NULL
,	NULL
respectively	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cells	NULL
develop	NULL
from	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
differentiation	NULL
process	NULL
is	NULL
initiated	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
TCR	NULL
and	NULL
directed	NULL
by	NULL
cytokines	NULL
present	NULL
during	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
response	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IL-4	NULL
promotes	NULL
Th2	NULL
development	NULL
(	NULL
5-7	NULL
)	NULL
,	NULL
whereas	NULL
IL-12	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
Th1	NULL
cells	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

IL-4	NULL
activates	NULL
Stat6	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
and	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statd4	NULL
in	NULL
developing	NULL
and	NULL
differentiated	NULL
Th1	NULL
cells	NULL
(	NULL
14-19	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
these	NULL
two	NULL
STAT	NULL
factors	NULL
is	NULL
essential	NULL
for	NULL
T	NULL
cell	NULL
subset	NULL
development	NULL
,	NULL
since	NULL
Stat6-deficient	NULL
T	NULL
lymphocytes	NULL
fail	NULL
to	NULL
differentiate	NULL
into	NULL
Th2	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
(	NULL
20-22	NULL
)	NULL
,	NULL
and	NULL
the	NULL
analysis	NULL
of	NULL
Stat4	NULL
'	NULL
-deficient	NULL
mice	NULL
revealed	NULL
that	NULL
Statd4	NULL
is	NULL
essential	NULL
for	NULL
Th1	NULL
cell	NULL
differentiation	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
IL-12	NULL
signaling	NULL
pathway	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th	NULL
cells	NULL
.	NULL

The	NULL
subunit	NULL
,	NULL
a	NULL
ligand-binding	NULL
and	NULL
signal-transducing	NULL
component	NULL
of	NULL
the	NULL
IL-12R	NULL
(	NULL
25	NULL
)	NULL
,	NULL
is	NULL
expressed	NULL
on	NULL
human	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
Th2	NULL
,	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Triggering	NULL
of	NULL
the	NULL
Ag	NULL
receptor	NULL
on	NULL
naive	NULL
T	NULL
cells	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
initial	NULL
expression	NULL
of	NULL
functional	NULL
IL-12Rs	NULL
,	NULL
which	NULL
are	NULL
quickly	NULL
lost	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
cells	NULL
along	NULL
the	NULL
Th2	NULL
pathway	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
TCR-mediated	NULL
regulation	NULL
,	NULL
the	NULL
IL-12RfB2	NULL
subunit	NULL
can	NULL
be	NULL
up-regulated	NULL
by	NULL
IL-12	NULL
(	NULL
19	NULL
)	NULL
.	NULL

T	NULL
he	NULL
discovery	NULL
of	NULL
polarized	NULL
subsets	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
that	NULL
*Roche	NULL
Milano	NULL
Ricerche	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Inflammation/Autoim-mune	NULL
Diseases	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Inc.	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
07110	NULL
Received	NULL
for	NULL
publication	NULL
April	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
August	NULL
24	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Lars	NULL
Rogge	NULL
,	NULL
Roche	NULL
Milano	NULL
Ricerche	NULL
,	NULL
Via	NULL
Olgettina	NULL
58	NULL
,	NULL
1-20132	NULL
Milan	NULL
,	NULL
Italy	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
lars.rogge	NULL
@	NULL
roche.com	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
6567-6574	NULL
.	NULL

IFNs	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
Th1	NULL
cell	NULL
development	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
human	NULL
cord	NULL
blood	NULL
leukocytes	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-	NULL
«	NULL
,	NULL
but	NULL
not	NULL
IFN-y	NULL
,	NULL
develop	NULL
into	NULL
IFN-y-producing	NULL
Th1	NULL
cells	NULL
even	NULL
when	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
Abs	NULL
.	NULL

The	NULL
Th1	NULL
cells	NULL
generated	NULL
in	NULL
this	NULL
manner	NULL
express	NULL
the	NULL
mRNA	NULL
and	NULL
are	NULL
responsive	NULL
to	NULL
IL-12	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
human	NULL
cells	NULL
,	NULL
IFN-	NULL
@	NULL
/B	NULL
are	NULL
unable	NULL
to	NULL
induce	NULL
Th1	NULL
development	NULL
and	NULL
prime	NULL
mouse	NULL
T	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
IL-12	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
investigated	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
species-specific	NULL
effect	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
on	NULL
the	NULL
selective	NULL
induction	NULL
of	NULL
Th1-type	NULL
immune	NULL
responses	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
,	NULL
by	NULL
phosphorylating	NULL
Statd4	NULL
in	NULL
human	NULL
,	NULL
but	NULL
not	NULL
in	NULL
mouse	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
promote	NULL
species-specific	NULL
induction	NULL
of	NULL
Th1-type	NULL
immune	NULL
responses	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
T	NULL
cell	NULL
responsiveness	NULL
to	NULL
IFN-a	NULL
is	NULL
not	NULL
lost	NULL
during	NULL
Th2	NULL
differentiation	NULL
,	NULL
we	NULL
explored	NULL
the	NULL
effect	NULL
of	NULL
IFN-a-induced	NULL
Stat4	NULL
activation	NULL
on	NULL
the	NULL
phenotype	NULL
of	NULL
fully	NULL
differentiated	NULL
Th2	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Generation	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
from	NULL
cord	NULL
blood	NULL
leukocytes	NULL
Human	NULL
neonatal	NULL
leukocytes	NULL
were	NULL
isolated	NULL
from	NULL
freshly	NULL
collected	NULL
,	NULL
heparin-ized	NULL
,	NULL
neonatal	NULL
blood	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Swe-den	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Monocytes	NULL
were	NULL
removed	NULL
by	NULL
one	NULL
round	NULL
of	NULL
plastic	NULL
adherence	NULL
,	NULL
and	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
negative	NULL
selection	NULL
with	NULL
an	NULL
Ab	NULL
mixture	NULL
and	NULL
magnetic	NULL
activated	NULL
cell	NULL
sorting	NULL
,	NULL
according	NULL
to	NULL
a	NULL
protocol	NULL
supplied	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
CD4*	NULL
T	NULL
cell	NULL
isolation	NULL
kit	NULL
,	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Neonatal	NULL
T	NULL
cell	NULL
preparations	NULL
were	NULL
>	NULL
97	NULL
%	NULL
CD45	NULL
RA*	NULL
and	NULL
>	NULL
99	NULL
%	NULL
CD4*	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
neonatal	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
irradiated	NULL
(	NULL
6000	NULL
rad	NULL
)	NULL
,	NULL
autologous	NULL
monocytes	NULL
and	NULL
2	NULL
pg/ml	NULL
PHA	NULL
(	NULL
Wellcome	NULL
,	NULL
Beckenham	NULL
,	NULL
U.K.	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
ng/ml	NULL
IL-12	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
200	NULL
ng/ml	NULL
neutralizing	NULL
anti-IL-4	NULL
Abs	NULL
(	NULL
18500D	NULL
,	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
Th1	NULL
cultures	NULL
,	NULL
or	NULL
1	NULL
ng/ml	NULL
IL-4	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
2	NULL
pg/ml	NULL
neutralizing	NULL
anti-IL-12	NULL
Abs	NULL
17F7	NULL
and	NULL
20C2	NULL
(	NULL
provided	NULL
by	NULL
M.	NULL
Gately	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
Th2	NULL
cultures	NULL
,	NULL
respectively	NULL
.	NULL

To	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
IFNs	NULL
on	NULL
Th	NULL
cell	NULL
development	NULL
,	NULL
1000	NULL
U/ml	NULL
of	NULL
IFN-	NULL
«	NULL
(	NULL
Ro-feron	NULL
A	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
IFN-y	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
or	NULL
IFN-B	NULL
(	NULL
Frone	NULL
,	NULL
Ares	NULL
Serono	NULL
,	NULL
Geneva	NULL
,	NULL
Swit-zerland	NULL
)	NULL
was	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
priming	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
Abs	NULL
(	NULL
Th2-inducing	NULL
conditions	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
on	NULL
day	NULL
4	NULL
and	NULL
expanded	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FetalClone	NULL
I	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
penicillin-streptomycin	NULL
containing	NULL
100	NULL
U/ml	NULL
IL-2	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6568	NULL
Purification	NULL
and	NULL
stimulation	NULL
of	NULL
CD45RA*	NULL
T	NULL
cells	NULL
Human	NULL
PBMC	NULL
from	NULL
healthy	NULL
donors	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
by	NULL
Ficoll-Paque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Monocytes	NULL
were	NULL
depleted	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
plastic	NULL
adherence	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
were	NULL
depleted	NULL
by	NULL
adherence	NULL
to	NULL
nylon	NULL
wool	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

CD45RA	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
immunomagnetic	NULL
negative	NULL
selection	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
mAbs	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
CD3/CD45RA*	NULL
T	NULL
cells	NULL
using	NULL
this	NULL
procedure	NULL
was	NULL
typically	NULL
>	NULL
98	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Purified	NULL
CD4SRA	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
TR66	NULL
)	NULL
(	NULL
29	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
(	NULL
200	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
IL-4	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
generation	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
,	NULL
respectively	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
IFNs	NULL
exert	NULL
their	NULL
functional	NULL
effects	NULL
directly	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
IFN-a	NULL
,	NULL
IFN-	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
was	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
stimulation	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
on	NULL
day	NULL
3	NULL
and	NULL
expanded	NULL
in	NULL
complete	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
IL-2	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
T	NULL
cell	NULL
clones	NULL
GL93	NULL
and	NULL
D4.11	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
Lol	NULL
pl-specific	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
generated	NULL
from	NULL
PBMC	NULL
of	NULL
two	NULL
Lol	NULL
p1	NULL
allergic	NULL
subjects	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
three	NULL
Lol	NULL
p1-specific	NULL
T	NULL
cell	NULL
clones	NULL
that	NULL
we	NULL
selected	NULL
for	NULL
this	NULL
study	NULL
had	NULL
a	NULL
polarized	NULL
cytokine	NULL
profile	NULL
.	NULL

Two	NULL
(	NULL
D4.11	NULL
and	NULL
E4.1	NULL
)	NULL
produced	NULL
IL-4	NULL
but	NULL
not	NULL
IFN-y	NULL
and	NULL
were	NULL
categorized	NULL
as	NULL
Th2	NULL
clones	NULL
,	NULL
and	NULL
one	NULL
(	NULL
ET3.22	NULL
)	NULL
that	NULL
was	NULL
able	NULL
to	NULL
produce	NULL
IFN-y	NULL
but	NULL
not	NULL
IL-4	NULL
was	NULL
categorized	NULL
as	NULL
a	NULL
Th1	NULL
clone	NULL
.	NULL

Th1	NULL
clone	NULL
GL93	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
hepatitis	NULL
virus	NULL
8	NULL
Ag	NULL
and	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
cytokine	NULL
production	NULL
,	NULL
105/0.2	NULL
ml	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
0.1	NULL
pg/ml	NULL
;	NULL
CLB-T3/4E	NULL
,	NULL
CLB	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
and	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
PharMingen	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IFN-	NULL
«	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
.	NULL

Cell-free	NULL
supernatants	NULL
were	NULL
collected	NULL
after	NULL
24	NULL
h	NULL
,	NULL
and	NULL
IFN-y	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
specific	NULL
sandwich	NULL
ELISA	NULL
following	NULL
a	NULL
protocol	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Single	NULL
cell	NULL
analysis	NULL
of	NULL
intracellular	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
production	NULL
Single	NULL
cell	NULL
analysis	NULL
of	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
production	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
collected	NULL
7	NULL
days	NULL
after	NULL
priming	NULL
and	NULL
washed	NULL
,	NULL
and	NULL
10°	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

Brefeldin	NULL
A	NULL
(	NULL
10	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
h.	NULL
Then	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
and	NULL
permeabilized	NULL
with	NULL
saponin	NULL
.	NULL

Fixed	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
anti-human	NULL
IFN-y-FITC	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
anti-human	NULL
IL-4-PE	NULL
(	NULL
PharMingen	NULL
)	NULL
following	NULL
a	NULL
protocol	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
anti-human	NULL
IL-12RB2	NULL
mAbs	NULL
Lewis	NULL
rats	NULL
were	NULL
immunized	NULL
and	NULL
boosted	NULL
with	NULL
purified	NULL
recombinant	NULL
hull-12RB2-IgG1	NULL
fusion	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
human	NULL
IL-12RB2	NULL
and	NULL
the	NULL
Fc	NULL
portion	NULL
of	NULL
human	NULL
IgG1	NULL
(	NULL
D.	NULL
H.	NULL
Presky	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Splenocytes	NULL
from	NULL
the	NULL
immunized	NULL
rat	NULL
were	NULL
isolated	NULL
and	NULL
fused	NULL
to	NULL
the	NULL
SP2/0	NULL
mouse	NULL
myeloma	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
Ab-producing	NULL
hybridomas	NULL
were	NULL
produced	NULL
by	NULL
standard	NULL
methods	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Hybridoma	NULL
supernatants	NULL
were	NULL
screened	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
human	NULL
IL-12Rf2-ex-pressing	NULL
Ba/F3	NULL
cell	NULL
line	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
the	NULL
mAb	NULL
2B6	NULL
bound	NULL
to	NULL
the	NULL
human	NULL
IL-12RB2-expressing	NULL
transfectants	NULL
,	NULL
but	NULL
not	NULL
the	NULL
parental	NULL
Ba/F3	NULL
cell	NULL
line	NULL
.	NULL

Purified	NULL
2B6	NULL
,	NULL
a	NULL
rat	NULL
IgG2a	NULL
,	NULL
was	NULL
prepared	NULL
by	NULL
sequential	NULL
caprylic	NULL
acid	NULL
and	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Cell	NULL
surface	NULL
staining	NULL
of	NULL
IL-12R	NULL
subunits	NULL
Cells	NULL
were	NULL
stained	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
purified	NULL
rat	NULL
anti-human	NULL
IL-12RB1	NULL
mAb	NULL
(	NULL
2B10	NULL
)	NULL
(	NULL
36	NULL
)	NULL
,	NULL
rat	NULL
anti-human	NULL
IL-12RB2	NULL
mAb	NULL
(	NULL
2B6	NULL
)	NULL
,	NULL
and	NULL
isotype-matched	NULL
control	NULL
Abs	NULL
at	NULL
4°C	NULL
for	NULL
45	NULL
min	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
with	NULL
cold	NULL
FACS-buffer	NULL
(	NULL
PBS	NULL
,	NULL
2	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
as	NULL
before	NULL
with	NULL
2	NULL
ug/ml	NULL
of	NULL
biotinylated	NULL
polyclonal	NULL
anti-mouse	NULL
or	NULL
anti-rat	NULL
IgG	NULL
Ab	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
in	NULL
FACS	NULL
buffer	NULL
and	NULL
incubated	NULL
with	NULL
streptavidin-phycoerythrin	NULL
(	NULL
1/	NULL
100	NULL
;	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
)	NULL
.	NULL

After	NULL
two	NULL
additional	NULL
washes	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
FACS	NULL
buffer	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
,	NULL
immunoprecipitations	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
T	NULL
cell	NULL
lines	NULL
generated	NULL
from	NULL
human	NULL
cord	NULL
blood	NULL
leukocytes	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
9	NULL
after	NULL
priming	NULL
,	NULL
and	NULL
mouse	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
6	NULL
days	NULL
after	NULL
STAT	NULL
ACTIVATION	NULL
IN	NULL
DEVELOPING	NULL
AND	NULL
DIFFERENTIATED	NULL
Th	NULL
CELLS	NULL
stimulation	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
'	NULL
)	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/ml	NULL
!	NULL
)	NULL

or	NULL
IFN-	NULL
,	NULL
IFN-B	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
1,000	NULL
U/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
before	NULL
lysing	NULL
the	NULL
cell	NULL
pellet	NULL
in	NULL
250	NULL
pl	NULL
of	NULL
IP	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
;	NULL
150	NULL
mM	NULL
NaCl	NULL
;	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
;	NULL
1	NULL
mM	NULL
EGTA	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
;	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
0.25	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
10	NULL
ug/ml	NULL
!	NULL

aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
NaF	NULL
;	NULL
1	NULL
mM	NULL
4-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
-benzene	NULL
sulfonyl	NULL
fluoride	NULL
hydrochloride	NULL
(	NULL
AEBSF	NULL
)	NULL
,	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
incubated	NULL
30	NULL
min	NULL
on	NULL
a	NULL
shaker	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
insoluble	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
(	NULL
13,000	NULL
rpm	NULL
,	NULL
4°C	NULL
,	NULL
30	NULL
min	NULL
)	NULL
.	NULL

Stat4	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
anti-Stat4	NULL
an-tisera	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Following	NULL
transfer	NULL
to	NULL
nitrocellulose	NULL
,	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
Ab	NULL
4G10	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
immunoreactive	NULL
bands	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
ECL	NULL
Western	NULL
blotting	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Italy	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
company	NULL
's	NULL
protocols	NULL
.	NULL

To	NULL
control	NULL
for	NULL
equal	NULL
protein	NULL
loading	NULL
,	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat4	NULL
antisera	NULL
.	NULL

Generation	NULL
of	NULL
mouse	NULL
Thl1	NULL
and	NULL
Th2	NULL
lines	NULL
from	NULL
DO.11.10-transgenic	NULL
CD4*	NULL
T	NULL
cell	NULL
cultures	NULL
Mel-14	NULL
``	NULL
®	NULL
``	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
of	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
(	NULL
37	NULL
)	NULL
by	NULL
positive	NULL
selection	NULL
using	NULL
anti-CD4~FITC	NULL
(	NULL
PharMingen	NULL
)	NULL
and	NULL
an	NULL
anti-FITC	NULL
multisort	NULL
kit	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
followed	NULL
by	NULL
positive	NULL
selection	NULL
of	NULL
Mel-14	NULL
``	NULL
*	NULL
``	NULL
cells	NULL
using	NULL
anti-CD62L	NULL
microbeads	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
.	NULL

Naive	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
cells/well	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
0.3	NULL
uM	NULL
OVA	NULL
peptide	NULL
323-339	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
BALB/c	NULL
splenocytes	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/well	NULL
)	NULL
as	NULL
APC	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
2	NULL
ml	NULL
in	NULL
24-well	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
pg/ml	NULL
IL-12	NULL
(	NULL
provided	NULL
by	NULL
M.	NULL
Gately	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
10	NULL
ug/tol	NULL
anti-IL-4	NULL
mAb	NULL
(	NULL
11B11	NULL
)	NULL
to	NULL
promote	NULL
Th1	NULL
phenotype	NULL
development	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
and	NULL
10	NULL
ug/ml	NULL
anti-IL-12	NULL
mAb	NULL
10F6	NULL
(	NULL
provided	NULL
by	NULL
M.	NULL
Gately	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
to	NULL
promote	NULL
Th2	NULL
phenotype	NULL
development	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
expanded	NULL
in	NULL
complete	NULL
medium	NULL
supplemented	NULL
with	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
provided	NULL
by	NULL
M.	NULL
Gately	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
harvested	NULL
on	NULL
day	NULL
5	NULL
or	NULL
7	NULL
.	NULL

The	NULL
Th	NULL
phenotype	NULL
was	NULL
determined	NULL
by	NULL
intracellular	NULL
staining	NULL
for	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
production	NULL
after	NULL
restimulation	NULL
with	NULL
PMA/iono-mycin	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
IL-12RB2	NULL
transcripts	NULL
in	NULL
mouse	NULL
Th	NULL
cells	NULL
RNase	NULL
protection	NULL
assays	NULL
to	NULL
analyze	NULL
IL-12R	NULL
32	NULL
transcripts	NULL
in	NULL
mouse	NULL
Th	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
332-bp	NULL
Sacl	NULL
DNA	NULL
fragment	NULL
from	NULL
the	NULL
mouse	NULL
IL-12RB2	NULL
subunit	NULL
(	NULL
25	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
pSPUTK	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
was	NULL
linearized	NULL
with	NULL
EcoRI	NULL
,	NULL
and	NULL
radiolabeled	NULL
antisense	NULL
transcripts	NULL
were	NULL
synthesized	NULL
with	NULL
SP6	NULL
polymerase	NULL
and	NULL
a	NULL
commercial	NULL
kit	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
cells	NULL
using	NULL
Ultraspec	NULL
total	NULL
RNA	NULL
extraction	NULL
reagent	NULL
(	NULL
Biotec	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
RNA	NULL
probes	NULL
were	NULL
hybridized	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
and	NULL
RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
company	NULL
's	NULL
protocol	NULL
.	NULL

Products	NULL
were	NULL
resolved	NULL
on	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
the	NULL
protected	NULL
fragments	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
radioactivity	NULL
present	NULL
in	NULL
the	NULL
protected	NULL
fragments	NULL
was	NULL
also	NULL
quantitated	NULL
using	NULL
a	NULL
MolecularImager	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

An	NULL
188	NULL
RNA	NULL
probe	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

Expression	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
in	NULL
mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
Mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
DO.11.10-transgenic	NULL
CD4*	NULL
T	NULL
cell	NULL
cultures	NULL
were	NULL
harvested	NULL
5	NULL
days	NULL
after	NULL
stimulation	NULL
and	NULL
incubated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
or	NULL
without	NULL
IFN-	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
biotinylated	NULL
anti-clonotypic	NULL
mAb	NULL
KJ1-26	NULL
(	NULL
41	NULL
)	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
streptavidin-FITC	NULL
(	NULL
PharMingen	NULL
)	NULL
and	NULL
anti-H-2K-PE	NULL
(	NULL
PharMingen	NULL
)	NULL
or	NULL
an	NULL
isotype-matched	NULL
control	NULL
mAb	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Results	NULL
IFN-	NULL
@	NULL
/B	NULL
act	NULL
directly	NULL
on	NULL
human	NULL
T	NULL
cells	NULL
to	NULL
promote	NULL
Thl	NULL
development	NULL
To	NULL
examine	NULL
the	NULL
roles	NULL
of	NULL
IFN-a	NULL
,	NULL
IFN-	NULL
$	NULL
B	NULL
,	NULL
and	NULL
IFN-y	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
Th	NULL
cell	NULL
subsets	NULL
,	NULL
we	NULL
generated	NULL
T	NULL
cell	NULL
lines	NULL
from	NULL
CD4*	NULL
,	NULL
CD45RA	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
cord	NULL
blood	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
irradiated	NULL
allogeneic	NULL
monocytes	NULL
and	NULL
PHA	NULL
in	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6569	NULL
FIGURE	NULL
1	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
IFN-	NULL
,	NULL
IFN-	NULL
,	NULL
and	NULL
IFN-y	NULL
on	NULL
human	NULL
Th	NULL
cell	NULL
differentiation	NULL
.	NULL

Neonatal	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
irradi-ated	NULL
,	NULL
allogeneic	NULL
monocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
following	NULL
cytokines	NULL
and	NULL
anti-cytokine	NULL
mAbs	NULL
:	NULL
A	NULL
,	NULL
IL-12	NULL
and	NULL
anti-IL-4	NULL
;	NULL
B	NULL
,	NULL
IL-4	NULL
and	NULL
anti-IL-12	NULL
;	NULL
C	NULL
,	NULL
IL-4	NULL
,	NULL
anti-IL-12	NULL
,	NULL
and	NULL
IFN-	NULL
;	NULL
D	NULL
,	NULL
IL-4	NULL
,	NULL
anti-IL-12	NULL
,	NULL
and	NULL
IFN-	NULL
;	NULL
£	NULL
,	NULL
IL-4	NULL
,	NULL
anti-IL-12	NULL
,	NULL
and	NULL
IFN-y	NULL
.	NULL

Seven	NULL
days	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
the	NULL
intracellular	NULL
production	NULL
of	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

IL-4	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
or	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAb	NULL
,	NULL
respectively	NULL
.	NULL

IFN-	NULL
«	NULL
,	NULL
IFN-B	NULL
,	NULL
or	NULL
IFN-y	NULL
were	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
priming	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
(	NULL
Th2-inducing	NULL
conditions	NULL
)	NULL
.	NULL

The	NULL
Th	NULL
phenotype	NULL
was	NULL
determined	NULL
7	NULL
days	NULL
after	NULL
stimulation	NULL
.	NULL

After	NULL
restimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
productions	NULL
were	NULL
determined	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
by	NULL
intracellular	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Neonatal	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAbs	NULL
developed	NULL
mostly	NULL
into	NULL
Th1	NULL
cells	NULL
(	NULL
55	NULL
%	NULL
IFN-y-producing	NULL
cells	NULL
vs	NULL
4	NULL
%	NULL
IL-4	NULL
producers	NULL
and	NULL
8	NULL
%	NULL
double	NULL
pro-ducers	NULL
;	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
whereas	NULL
priming	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
induced	NULL
development	NULL
of	NULL
a	NULL
polarized	NULL
Th2	NULL
population	NULL
(	NULL
0.5	NULL
%	NULL
IFN-y-producing	NULL
cells	NULL
vs	NULL
23	NULL
%	NULL
IL-4	NULL
produc-ers	NULL
;	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IFN-a	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
or	NULL
IFN-B	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
at	NULL
the	NULL
time	NULL
of	NULL
priming	NULL
under	NULL
Th2-inducing	NULL
conditions	NULL
(	NULL
IL-4	NULL
and	NULL
anti-IL-12	NULL
mAbs	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
cells	NULL
producing	NULL
IFN-y	NULL
(	NULL
11	NULL
and	NULL
20	NULL
%	NULL
compared	NULL
with	NULL
0.5	NULL
%	NULL
)	NULL
and	NULL
a	NULL
reduction	NULL
(	NULL
two-	NULL
to	NULL
fourfold	NULL
)	NULL
in	NULL
cells	NULL
producing	NULL
IL-4	NULL
(	NULL
12	NULL
and	NULL
5	NULL
%	NULL
compared	NULL
with	NULL
23	NULL
%	NULL
)	NULL
.	NULL

IFN-y	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
was	NULL
less	NULL
effective	NULL
in	NULL
inducing	NULL
Th1	NULL
cell	NULL
development	NULL
(	NULL
Fig	NULL
.	NULL

1€	NULL
)	NULL
:	NULL
only	NULL
a	NULL
marginal	NULL
increase	NULL
in	NULL
cells	NULL
producing	NULL
IFN-y	NULL
(	NULL
2.9	NULL
%	NULL
compared	NULL
with	NULL
0.5	NULL
%	NULL
)	NULL
and	NULL
a	NULL
minor	NULL
decrease	NULL
in	NULL
IL-4-producing	NULL
cells	NULL
(	NULL
20	NULL
%	NULL
compared	NULL
with	NULL
23	NULL
%	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
cultures	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
,	NULL
and	NULL
IFN-y	NULL
.	NULL

Priming	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-	NULL
«	NULL
,	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
,	NULL
and	NULL
anti-IL-12	NULL
mAb	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
IFN-a	NULL
@	NULL
is	NULL
directly	NULL
implicated	NULL
in	NULL
Th1	NULL
development	NULL
rather	NULL
than	NULL
through	NULL
the	NULL
action	NULL
of	NULL
IL-4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
and	NULL
extend	NULL
our	NULL
previous	NULL
finding	NULL
that	NULL
cord	NULL
blood	NULL
leukocytes	NULL
primed	NULL
with	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
anti-IL-12	NULL
mAbs	NULL
,	NULL
and	NULL
IFN-a	NULL
secrete	NULL
predominantly	NULL
IFN-y	NULL
upon	NULL
restimulation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
whether	NULL
IFN-	NULL
@	NULL
/B	NULL
promote	NULL
Th1	NULL
development	NULL
by	NULL
acting	NULL
directly	NULL
on	NULL
naive	NULL
T	NULL
cells	NULL
or	NULL
whether	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
is	NULL
required	NULL
.	NULL

Purified	NULL
CD45RA	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
to	NULL
induce	NULL
Th1	NULL
development	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
to	NULL
promote	NULL
Th2	NULL
development	NULL
,	NULL
respectively	NULL
.	NULL

IFN-	NULL
,	NULL
IFN-	NULL
$	NULL
B	NULL
,	NULL
or	NULL
IFN-y	NULL
was	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
CD3	NULL
stimulation	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
.	NULL

After	NULL
3	NULL
days	NULL
of	NULL
cul-ture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
expanded	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
days	NULL
in	NULL
medium	NULL
containing	NULL
IL-2	NULL
.	NULL

The	NULL
IL-12	NULL
responsiveness	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
was	NULL
used	NULL
as	NULL
a	NULL
readout	NULL
to	NULL
determine	NULL
the	NULL
Th	NULL
phenotype	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IL-12	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
cultures	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
unable	NULL
to	NULL
activate	NULL
this	NULL
signaling	NULL
pathway	NULL
in	NULL
cultures	NULL
that	NULL
had	NULL
been	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
addition	NULL
of	NULL
IFN-a	NULL
@	NULL
or	NULL
IFN-	NULL
at	NULL
priming	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Th2-inducing	NULL
cytokine	NULL
IL-4	NULL
resulted	NULL
in	NULL
the	NULL
development	NULL
of	NULL
IL-12-responsive	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
IFN-y	NULL
did	NULL
not	NULL
significantly	NULL
increase	NULL
IL-12	NULL
responsiveness	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Zane	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-12	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
cultures	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-w/B	NULL
to	NULL
signal	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
correlates	NULL
with	NULL
IL-12RB2	NULL
expression	NULL
.	NULL

Surface	NULL
IL-12R	NULL
expression	NULL
was	NULL
monitored	NULL
using	NULL
mAbs	NULL
directed	NULL
against	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
subunits	NULL
of	NULL
the	NULL
IL-12R	NULL
.	NULL

Fig	NULL
.	NULL

2B	NULL
shows	NULL
that	NULL
while	NULL
IL-12RB1	NULL
was	NULL
expressed	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
regardless	NULL
of	NULL
the	NULL
cytokines	NULL
present	NULL
at	NULL
priming	NULL
,	NULL
IL-12RB2	NULL
was	NULL
selectively	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
or	NULL
IFN-	NULL
«	NULL
/	NULL
$	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
IL-12	NULL
,	NULL
IFN-a	NULL
and	NULL
IFN-B	NULL
act	NULL
directly	NULL
on	NULL
human	NULL
T	NULL
cells	NULL
to	NULL
promote	NULL
the	NULL
development	NULL
of	NULL
Th1-type	NULL
cells	NULL
.	NULL

IFN-a	NULL
does	NULL
not	NULL
induce	NULL
the	NULL
development	NULL
of	NULL
mouse	NULL
Th1	NULL
cells	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
human	NULL
cells	NULL
,	NULL
IFN-	NULL
@	NULL
/B	NULL
could	NULL
not	NULL
induce	NULL
Th1	NULL
development	NULL
and	NULL
IL-12	NULL
responsiveness	NULL
in	NULL
mouse	NULL
T	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

IFN-y	NULL
,	NULL
however	NULL
,	NULL
induced	NULL
IL-12-responsive	NULL
mouse	NULL
T	NULL
cells	NULL
by	NULL
up-regulating	NULL
the	NULL
IL-12R	NULL
$	NULL
B2	NULL
subunit	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
apparent	NULL
differences	NULL
in	NULL
IFN	NULL
action	NULL
in	NULL
the	NULL
two	NULL
species	NULL
,	NULL
we	NULL
compared	NULL
side	NULL
by	NULL
side	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
on	NULL
human	NULL
and	NULL
mouse	NULL
Th	NULL
subset	NULL
differentiation	NULL
.	NULL

Mouse	NULL
OVA-specific	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
purified	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
specific	NULL
for	NULL
OVA	NULL
peptide	NULL
323-339	NULL
with	NULL
OVA	NULL
peptide	NULL
presented	NULL
by	NULL
mitomycin	NULL
C-treated	NULL
BALB/c	NULL
splenocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
or	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
,	NULL
respectively	NULL
(	NULL
16	NULL
,	NULL
38	NULL
)	NULL
.	NULL

At	NULL
priming	NULL
,	NULL
IFN-a	NULL
or	NULL
IFN-y	NULL
was	NULL
added	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
.	NULL

The	NULL
Th	NULL
phenotype	NULL
of	NULL
these	NULL
lines	NULL
was	NULL
analyzed	NULL
by	NULL
staining	NULL
for	NULL
intracellular	NULL
cytokines	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
priming	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
induced	NULL
Th1	NULL
phenotype	NULL
development	NULL
,	NULL
whereas	NULL
priming	NULL
in	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6570	NULL
A	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
A	NULL
,	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
act	NULL
directly	NULL
on	NULL
T	NULL
cells	NULL
to	NULL
induce	NULL
IL-12	NULL
responsiveness	NULL
.	NULL

CD45RA*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
from	NULL
buffy	NULL
coats	NULL
and	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
in	NULL
STAT	NULL
ACTIVATION	NULL
IN	NULL
DEVELOPING	NULL
AND	NULL
DIFFERENTIATED	NULL
Th	NULL
CELLS	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
and	NULL
{	NULL
-	NULL
+	NULL
anti-cytokine	NULL
mAbs	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
harvested	NULL
9	NULL
days	NULL
after	NULL
priming	NULL
,	NULL
and	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
2.5	NULL
ng/ml	NULL
IL-12	NULL
followed	NULL
by	NULL
the	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
and	NULL
immunoprecipitation	NULL
with	NULL
anti-Statd4	NULL
antiserum	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
q	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
8	NULL
%	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
Ab	NULL
4G10	NULL
100	NULL
t	NULL
=	NULL
!	NULL

Jo	NULL
$	NULL
r	NULL
es	NULL
z	NULL
z	NULL
z	NULL
s	NULL
&	NULL
E	NULL
-	NULL
&	NULL
a	NULL
+	NULL
*	NULL
+	NULL
Cytokines	NULL
added	NULL
v-	NULL
t	NULL
£24	NULL
3	NULL
z	NULL
3	NULL
Z	NULL
z	NULL
at	NULL
priming	NULL
{	NULL
o-	NULL
ot	NULL
>	NULL
41	NULL
>	NULL
+	NULL
``	NULL
~	NULL
4	NULL
)	NULL
Blot	NULL
:	NULL
aa	NULL
ax	NULL
,	NULL
|Ka	NULL
anti-P-¥	NULL
IP	NULL
:	NULL
anti-Stat4	NULL
tto	NULL
amo	NULL
ous	NULL
ont	NULL
ts	NULL
tas	NULL
oms	NULL
tet	NULL
oe	NULL
&	NULL
gnti-Staltd	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
(	NULL
anti-P-Y	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
Stat4	NULL
expression	NULL
,	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat4	NULL
Abs	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Cell	NULL
surface	NULL
expression	NULL
of	NULL
IL-12R	NULL
subunits	NULL
on	NULL
human	NULL
Th	NULL
cells	NULL
.	NULL

CD4SRA	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
from	NULL
cord	NULL
blood	NULL
and	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indi-	NULL
1000	NULL
20	NULL
40	NULL
60	NULL
$	NULL
0	NULL
IL-12	NULL
+	NULL
anti-lL-4	NULL
IL-4	NULL
+	NULL
anti-lL-12	NULL
Fri	NULL
cated	NULL
cytokines	NULL
and	NULL
anti-cytokine	NULL
mAbs	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
5	NULL
days	NULL
after	NULL
priming	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
IL-12RB1	NULL
and	NULL
-B2	NULL
subunits	NULL
was	NULL
analyzed	NULL
with	NULL
rat-anti	NULL
hulL-12RfB1	NULL
mAb	NULL
2B10	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
and	NULL
rat-anti	NULL
hulL-12RB2	NULL
mAb	NULL
2B6	NULL
(	NULL
stippled	NULL
line	NULL
)	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
represents	NULL
staining	NULL
Relative	NULL
Cell	NULL
Number	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
IL-4	NULL
+	NULL
anti-lL-12	NULL
+	NULL
IFN-o	NULL
|	NULL
~	NULL
IL-4	NULL
+	NULL
ant-ilL-12	NULL
+	NULL
IFN-y	NULL
IL-4	NULL
+	NULL
anti-lL-12	NULL
+IFN-B	NULL
|	NULL
3	NULL
-	NULL
'	NULL
1	NULL
ne	NULL
with	NULL
an	NULL
isotype-matched	NULL
control	NULL
mAb	NULL
.	NULL

10°	NULL
WII	NULL
162	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
promoted	NULL
differentiation	NULL
of	NULL
Th2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IFN-a	NULL
or	NULL
IFN-y	NULL
at	NULL
priming	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
Th2	NULL
cytokine	NULL
profile	NULL
of	NULL
the	NULL
resulting	NULL
population	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
expression	NULL
of	NULL
the	NULL
IL-12RB2	NULL
subunit	NULL
and	NULL
IL-12	NULL
responsiveness	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

As	NULL
Abs	NULL
against	NULL
the	NULL
mouse	NULL
IL-12RB1	NULL
and	NULL
-B2	NULL
subunits	NULL
are	NULL
not	NULL
yet	NULL
available	NULL
,	NULL
transcripts	NULL
encoding	NULL
the	NULL
IL-12Rf1	NULL
and	NULL
-B2	NULL
subunits	NULL
were	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
observations	NULL
(	NULL
18	NULL
,	NULL
39	NULL
)	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
IL-12RB1	NULL
mRNA	NULL
expression	NULL
were	NULL
detected	NULL
in	NULL
mouse	NULL
Th	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
IL-12	NULL
up-regulates	NULL
the	NULL
expression	NULL
of	NULL
IL-12RB2	NULL
transcripts	NULL
in	NULL
activated	NULL
human	NULL
and	NULL
mouse	NULL
T	NULL
cells	NULL
(	NULL
19	NULL
,	NULL
39	NULL
)	NULL
,	NULL
we	NULL
used	NULL
induction	NULL
of	NULL
IL-12RB2	NULL
mRNA	NULL
by	NULL
IL-12	NULL
as	NULL
a	NULL
readout	NULL
for	NULL
IL-12	NULL
responsiveness	NULL
.	NULL

IL-12RB2	NULL
is	NULL
expressed	NULL
in	NULL
mouse	NULL
Th1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
culturing	NULL
Th1	NULL
cells	NULL
for	NULL
20	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
strongly	NULL
up-regulates	NULL
the	NULL
expression	NULL
of	NULL
IL-1	NULL
2R	NULL
$	NULL
2	NULL
(	NULL
Jane	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
IL-12R	NULL
.	NULL

T	NULL
cells	NULL
primed	NULL
under	NULL
Th2-inducing	NULL
conditions	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Jane	NULL
3	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
of	NULL
IFN-	NULL
«	NULL
did	NULL
not	NULL
express	NULL
IL-12RfB2	NULL
transcripts	NULL
,	NULL
and	NULL
IL-12	NULL
treatment	NULL
did	NULL
not	NULL
induce	NULL
IL-12RB2	NULL
mRNA	NULL
expression	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
priming	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
resulted	NULL
in	NULL
the	NULL
development	NULL
of	NULL
cells	NULL
that	NULL
express	NULL
IL-12RB2	NULL
transcripts	NULL
and	NULL
are	NULL
IL-12	NULL
responsive	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
,	NULL
when	NULL
restimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
secreted	NULL
IFN-y	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
with	NULL
mouse	NULL
T	NULL
cells	NULL
diverge	NULL
from	NULL
the	NULL
findings	NULL
in	NULL
the	NULL
human	NULL
system	NULL
,	NULL
where	NULL
priming	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
results	NULL
in	NULL
the	NULL
development	NULL
of	NULL
IFN-y-producing	NULL
cells	NULL
that	NULL
express	NULL
the	NULL
IL-12R	NULL
$	NULL
2	NULL
subunit	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

10	NULL
ns	NULL
r-	NULL
enor	NULL
10	NULL
%	NULL
40°	NULL
__	NULL
10	NULL
10	NULL
10	NULL
0	NULL
ao*o	NULL
``	NULL
_	NULL
as	NULL
'	NULL
_	NULL
ao	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
IFN-	NULL
@	NULL
/B	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stai4	NULL
in	NULL
human	NULL
,	NULL
but	NULL
not	NULL
in	NULL
mouse	NULL
,	NULL
Thl	NULL
and	NULL
Th2	NULL
cells	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
distinct	NULL
functional	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
on	NULL
human	NULL
and	NULL
mouse	NULL
Th	NULL
cell	NULL
development	NULL
originate	NULL
from	NULL
different	NULL
uses	NULL
of	NULL
signaling	NULL
molecules	NULL
,	NULL
we	NULL
analyzed	NULL
tyrosine	NULL
phosphorylation	NULL
30	NULL
€	NULL
o	NULL
€	NULL
T	NULL
S00	NULL
#	NULL
=	NULL
!	NULL

<	NULL
hoallhce	NULL
ps	NULL
ks	NULL
]	NULL
2	NULL
EP	NULL
Er	NULL
Cytoki	NULL
[	NULL
5	NULL
]	NULL
ytokines	NULL
added	NULL
3	NULL
$	NULL
$	NULL
&	NULL
$	NULL
&	NULL
atpriming	NULL
=	NULL
=	NULL
=	NULL
=+	NULL
=+	NULL
|	NULL
|	NULL
|	NULL
|	NULL
>	NULL
o	NULL
#	NULL
00	NULL
>	NULL
#	NULL
o-	NULL
#	NULL
o-	NULL
4	NULL
JL-12	NULL
treatment	NULL
tt	NULL
'	NULL
Ww	NULL
18§	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIGURE	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
IL-12R/32	NULL
transcripts	NULL
in	NULL
mouse	NULL
Th	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
naive	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
with	NULL
OVA	NULL
peptide	NULL
323-339	NULL
presented	NULL
by	NULL
mitomycin	NULL
C-treated	NULL
BALB/c	NULL
splenocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
on	NULL
day	NULL
6	NULL
and	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
of	NULL
IL-12	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
to	NULL
analyze	NULL
IL-12-induced	NULL
up-regulation	NULL
of	NULL
IL-12RB2	NULL
transcripts	NULL
.	NULL

Transcripts	NULL
encoding	NULL
the	NULL
IL-12R	NULL
2	NULL
subunit	NULL
(	NULL
upper	NULL
row	NULL
)	NULL
and	NULL
an	NULL
185	NULL
RNA	NULL
gene	NULL
fragment	NULL
as	NULL
loading	NULL
control	NULL
(	NULL
lower	NULL
row	NULL
)	NULL
were	NULL
quantitated	NULL
by	NULL
RNase	NULL
protection	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
Thi	NULL
Th2	NULL
o	NULL
--	NULL
o	NULL
a	NULL
P	NULL
2	NULL
y	NULL
o	NULL
a	NULL
P	NULL
2	NULL
z	NULL
5	NULL
I	NULL
Z	NULL
2	NULL
2	NULL
5	NULL
V	NULL
zZ	NULL
z	NULL
z	NULL
e	NULL
i	NULL
&	NULL
&	NULL
&	NULL
g	NULL
g	NULL
l	NULL
H	NULL
W	NULL
Blot	NULL
:	NULL
-	NULL
mB	NULL
CB	NULL
cin	NULL
meme	NULL
anti-P-¥	NULL
IP	NULL
:	NULL
anti-Stat4	NULL
Cn	NULL
fun	NULL
GIB	NULL
CBB	NULL
axe	NULL
--	NULL
-o	NULL
9B	NULL
at	NULL
&	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
Thi	NULL
Th2	NULL
m	NULL
--	NULL
--	NULL
--	NULL
34	NULL
--	NULL
--	NULL
-s	NULL
a	NULL
&	NULL
&	NULL
$	NULL
1	NULL
&	NULL
£	NULL
Blot	NULL
:	NULL
gous	NULL
3	NULL
anti-P-¥	NULL
4	NULL
IP	NULL
:	NULL
anti-Stat4	NULL
daze	NULL
tanh	NULL
can	NULL
tans	NULL
tans	NULL
tane	NULL
tame	NULL
gums	NULL
-	NULL
ANti-Stat4	NULL
Th1	NULL
8	NULL
E	NULL
3	NULL
a	NULL
8	NULL
153	NULL
10	NULL
B	NULL
Th2	NULL
S	NULL
®	NULL
CC	NULL
0	NULL
10	NULL
10°	NULL
o	NULL
10	NULL
``	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
FIGURE	NULL
4	NULL
.	NULL

A	NULL
,	NULL
IFN-	NULL
@	NULL
/f	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Thl1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
leukocytes	NULL
were	NULL
harvested	NULL
9	NULL
days	NULL
after	NULL
priming	NULL
,	NULL
and	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
,	NULL
IFN-a	NULL
,	NULL
IFN-	NULL
$	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/m	NULL
!	NULL
)	NULL

.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Statd	NULL
was	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
Stat4	NULL
activation	NULL
in	NULL
mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR-transgenic	NULL
CD4*	NULL
T	NULL
cell	NULL
cultures	NULL
were	NULL
harvested	NULL
7	NULL
days	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
,	NULL
IFN-a	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
was	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

C	NULL
,	NULL
IFN-a	NULL
induces	NULL
up-regulation	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
in	NULL
mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR-transgenic	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
or	NULL
without	NULL
IFN-a	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
and	NULL
stained	NULL
with	NULL
biotinylated	NULL
anti-clonotype	NULL
mAb	NULL
KJ1.26	NULL
followed	NULL
by	NULL
streptavidin-FITC	NULL
and	NULL
anti-H-2K-phycoerythrin	NULL
.	NULL

Histograms	NULL
are	NULL
gated	NULL
for	NULL
KJ1-26*	NULL
cells	NULL
and	NULL
show	NULL
the	NULL
level	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
(	NULL
H-2K	NULL
``	NULL
)	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
or	NULL
IFN-a	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
represents	NULL
staining	NULL
with	NULL
an	NULL
isotype-matched	NULL
control	NULL
mAb	NULL
.	NULL

of	NULL
Statd	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
IL-12	NULL
in	NULL
differentiating	NULL
human	NULL
and	NULL
mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
(	NULL
19	NULL
)	NULL
and	NULL
those	NULL
of	NULL
other	NULL
laboratories	NULL
(	NULL
16-18	NULL
)	NULL
,	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
human	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
Th2	NULL
,	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IFN-a	NULL
«	NULL
and	NULL
IFN-	NULL
$	NULL
were	NULL
very	NULL
efficient	NULL
in	NULL
activating	NULL
Stat4	NULL
in	NULL
human	NULL
Th1	NULL
cells	NULL
,	NULL
and	NULL
unlike	NULL
IL-12	NULL
,	NULL
they	NULL
also	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
Th2	NULL
lines	NULL
6571	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

IFN-y	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
did	NULL
not	NULL
induce	NULL
activation	NULL
of	NULL
Stat4	NULL
in	NULL
Th1	NULL
or	NULL
Th2	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
IFN-	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
mouse	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

DO11.10	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
were	NULL
exposed	NULL
to	NULL
IL-12	NULL
,	NULL
IFN-a	NULL
,	NULL
or	NULL
IFN-y	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Stat4	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
in	NULL
Th1	NULL
cells	NULL
,	NULL
but	NULL
neither	NULL
IFN-nor	NULL
IFN-y	NULL
induces	NULL
Stat4	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
mouse	NULL
Th1	NULL
or	NULL
Th2	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
respond	NULL
to	NULL
IFN-	NULL
by	NULL
up-regulating	NULL
class	NULL
I	NULL
molecules	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
mouse	NULL
T	NULL
cells	NULL
also	NULL
express	NULL
a	NULL
functional	NULL
IFN-	NULL
«	NULL
receptor	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
clear	NULL
evidence	NULL
for	NULL
a	NULL
species-specific	NULL
difference	NULL
in	NULL
IFN-	NULL
«	NULL
-in-duced	NULL
activation	NULL
of	NULL
the	NULL
Stat4	NULL
molecule	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
STAT	NULL
activation	NULL
on	NULL
cytokine	NULL
production	NULL
by	NULL
differentiated	NULL
human	NULL
T	NULL
cells	NULL
The	NULL
analysis	NULL
of	NULL
Stat4-	NULL
and	NULL
Staté-deficient	NULL
mice	NULL
has	NULL
demonstrated	NULL
the	NULL
crucial	NULL
role	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
transcription	NULL
programs	NULL
leading	NULL
to	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
polarized	NULL
Th1	NULL
and	NULL
Th2	NULL
subsets	NULL
,	NULL
respectively	NULL
(	NULL
20-24	NULL
)	NULL
.	NULL

An	NULL
important	NULL
question	NULL
is	NULL
whether	NULL
activation	NULL
of	NULL
a	NULL
specific	NULL
STAT	NULL
protein	NULL
in	NULL
differentiated	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
is	NULL
sufficient	NULL
to	NULL
alter	NULL
their	NULL
cytokine	NULL
secretion	NULL
pattern	NULL
.	NULL

Since	NULL
IFN-a	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
IL-12	NULL
,	NULL
induces	NULL
Stat4	NULL
phosphorylation	NULL
in	NULL
differentiating	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
established	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
stimulation	NULL
of	NULL
Th2	NULL
lines	NULL
and	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
results	NULL
in	NULL
IFN-y	NULL
production	NULL
.	NULL

Restimulation	NULL
of	NULL
Th2	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
and	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
@	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
IFN-y	NULL
production	NULL
.	NULL

Consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
we	NULL
detected	NULL
high	NULL
amounts	NULL
of	NULL
IFN-y	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
after	NULL
restimulation	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
Stat4	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
induce	NULL
IFN-y	NULL
production	NULL
by	NULL
differentiated	NULL
Th2	NULL
cells	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
tandem	NULL
site	NULL
present	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
IFN-y	NULL
gene	NULL
and	NULL
thus	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IFN-y	NULL
gene	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Discussion	NULL
Species-specific	NULL
regulation	NULL
of	NULL
Th	NULL
cell	NULL
development	NULL
by	NULL
IFNs	NULL
The	NULL
functions	NULL
of	NULL
IFN-	NULL
«	NULL
@	NULL
/B	NULL
and	NULL
IFN-y	NULL
in	NULL
inducing	NULL
differentiation	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
naive	NULL
T	NULL
cells	NULL
to	NULL
Th1-type	NULL
effector	NULL
cells	NULL
have	NULL
remained	NULL
controversial	NULL
.	NULL

Stimulation	NULL
of	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-	NULL
«	NULL
increases	NULL
the	NULL
frequency	NULL
of	NULL
IFN-y-secreting	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
allergen-specific	NULL
T	NULL
cell	NULL
clones	NULL
generated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
«	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
atopic	NULL
patients	NULL
demonstrate	NULL
a	NULL
shift	NULL
toward	NULL
the	NULL
ThO/1	NULL
phenotype	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
human	NULL
cord	NULL
blood	NULL
leukocytes	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
develop	NULL
into	NULL
IFN-y-producing	NULL
Th1	NULL
cells	NULL
,	NULL
even	NULL
when	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Th2-inducing	NULL
cytokine	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
.	NULL

The	NULL
Th1	NULL
cells	NULL
generated	NULL
in	NULL
this	NULL
manner	NULL
express	NULL
the	NULL
IL-12RB2	NULL
mRNA	NULL
and	NULL
are	NULL
responsive	NULL
to	NULL
IL-12	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IFN-a	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
an	NULL
important	NULL
cofactor	NULL
for	NULL
Th1	NULL
development	NULL
in	NULL
mice	NULL
(	NULL
26	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

IFN-y	NULL
can	NULL
rescue	NULL
IL-12RB2	NULL
mRNA	NULL
expression	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
restore	NULL
IL-12	NULL
responsiveness	NULL
in	NULL
early	NULL
developing	NULL
mouse	NULL
Th2	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
previously	NULL
described	NULL
effect	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
in	NULL
human	NULL
Th1	NULL
development	NULL
and	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
divergent	NULL
function	NULL
of	NULL
type	NULL
I	NULL
IFNs	NULL
when	NULL
comparing	NULL
human	NULL
and	NULL
mouse	NULL
Th	NULL
cell	NULL
development	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
previous	NULL
observation	NULL
(	NULL
19	NULL
)	NULL
,	NULL
IFN-	NULL
@	NULL
/B	NULL
induce	NULL
Th1	NULL
development	NULL
in	NULL
human	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Th2-inducing	NULL
cytokine	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
this	NULL
is	NULL
a	NULL
direct	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6572	NULL
A	NULL
antiCD3+antiCD28+	NULL
!	NULL

IFN-o	NULL
antiCD3+antiCD28+	NULL
]	NULL
L-12	NULL
antiCD3+antiCD28	NULL
unstimulated	NULL
Th2	NULL
antiCD3+antiCD28+IL-12	NULL
antiCD3+antiCD28	NULL
unstimulated	NULL
Th1	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
90	NULL
IFN-y	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

antiCD3+antiCD28+	NULL
!	NULL

IFN-u	NULL
antiCD3+antiCD28+IL-12	NULL
antiCD3+antiCD28	NULL
Unstimulated	NULL
D4.11	NULL
antiCD3+antiCD28+IFN-a	NULL
antiCD3+antiCD28+IL-12	NULL
antiCD3+antiCD28	NULL
Unstimulated	NULL
GL93	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
IFN-y	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

FIGURE	NULL
5	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
IFN-a	NULL
and	NULL
IL-12	NULL
on	NULL
IFN-y	NULL
production	NULL
by	NULL
differentiated	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Cord	NULL
blood-derived	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
were	NULL
harvested	NULL
14	NULL
days	NULL
after	NULL
priming	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
restimulated	NULL
in	NULL
0.2	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
0.1	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
ug/tol	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
or	NULL
IFN-a	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
IFN-y	NULL
production	NULL
was	NULL
analyzed	NULL
by	NULL
ELISA	NULL
.	NULL

Shown	NULL
is	NULL
the	NULL
mean	NULL
IFN-y	NULL
production	NULL
of	NULL
six	NULL
independently	NULL
derived	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
.	NULL

Thin	NULL
bars	NULL
represent	NULL
the	NULL
SD	NULL
.	NULL

B	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
GL93	NULL
and	NULL
D4.11	NULL
were	NULL
harvested	NULL
10	NULL
days	NULL
after	NULL
restimulation	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
restimulated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
IFN-y	NULL
production	NULL
was	NULL
analyzed	NULL
by	NULL
ELISA	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
Th1	NULL
clone	NULL
ET3.22	NULL
and	NULL
Th2	NULL
clone	NULL
B4.1	NULL
.	NULL

effect	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
it	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
APCs	NULL
or	NULL
exogenous	NULL
factors	NULL
other	NULL
than	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
.	NULL

Th1	NULL
cells	NULL
generated	NULL
by	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
are	NULL
comparable	NULL
to	NULL
IL-12-generated	NULL
Th1	NULL
cells	NULL
in	NULL
terms	NULL
of	NULL
cytokine	NULL
production	NULL
,	NULL
IL-12	NULL
responsiveness	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
subunit	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
provide	NULL
clear	NULL
evidence	NULL
that	NULL
human	NULL
Th1-type	NULL
immune	NULL
responses	NULL
can	NULL
develop	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
functions	NULL
of	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
and	NULL
IFN-y	NULL
in	NULL
mouse	NULL
T	NULL
cell	NULL
differentiation	NULL
,	NULL
we	NULL
generated	NULL
mouse	NULL
OVA-specific	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
from	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
(	NULL
16	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Neither	NULL
IFN-a	NULL
nor	NULL
IFN-y	NULL
,	NULL
when	NULL
added	NULL
at	NULL
priming	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAbs	NULL
,	NULL
had	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
cytokine	NULL
secretion	NULL
profile	NULL
of	NULL
the	NULL
resulting	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
findings	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
priming	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IFN-a	NULL
@	NULL
,	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-12RB2	NULL
transcripts	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
IL-12	NULL
responsive	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
IL-12-induced	NULL
up-regulation	NULL
of	NULL
IL-12RB2	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
Stat4	NULL
phosphorylation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

STAT	NULL
ACTIVATION	NULL
IN	NULL
DEVELOPING	NULL
AND	NULL
DIFFERENTIATED	NULL
Th	NULL
CELLS	NULL
Restimulation	NULL
of	NULL
these	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
results	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
(	NULL
18	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
IFN-y	NULL
contributes	NULL
to	NULL
Thl	NULL
development	NULL
in	NULL
mice	NULL
,	NULL
whereas	NULL
IFN-a	NULL
has	NULL
no	NULL
effect	NULL
,	NULL
unlike	NULL
previous	NULL
suggestions	NULL
made	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
transgenic	NULL
mice	NULL
expressing	NULL
IFN-	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
rat	NULL
insulin	NULL
promoter	NULL
(	NULL
48	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
IFN-	NULL
@	NULL
/B	NULL
act	NULL
directly	NULL
on	NULL
human	NULL
,	NULL
but	NULL
not	NULL
mouse	NULL
,	NULL
T	NULL
cells	NULL
to	NULL
induce	NULL
Th1	NULL
development	NULL
,	NULL
whereas	NULL
IFN-y	NULL
acts	NULL
in	NULL
both	NULL
species	NULL
in	NULL
at	NULL
least	NULL
two	NULL
ways	NULL
;	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
IFN-y	NULL
induces	NULL
Th1	NULL
development	NULL
by	NULL
enhancing	NULL
IL-12-production	NULL
by	NULL
human	NULL
and	NULL
mouse	NULL
phagocytic	NULL
cells	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
it	NULL
up-regulates	NULL
the	NULL
expression	NULL
of	NULL
functional	NULL
IL-12Rs	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
rendering	NULL
the	NULL
cells	NULL
more	NULL
responsive	NULL
to	NULL
IL-12	NULL
(	NULL
18	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IL-12	NULL
responsiveness	NULL
is	NULL
much	NULL
stronger	NULL
in	NULL
mouse	NULL
than	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
the	NULL
expression	NULL
of	NULL
IL-12R	NULL
$	NULL
2	NULL
is	NULL
up-regulated	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
in	NULL
mouse	NULL
rather	NULL
than	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
in	NULL
mice	NULL
IFN-y	NULL
provides	NULL
a	NULL
signal	NULL
for	NULL
initiating	NULL
Th1	NULL
development	NULL
,	NULL
the	NULL
full	NULL
progression	NULL
of	NULL
which	NULL
requires	NULL
IL-12-induced	NULL
signaling	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
IFN-	NULL
@	NULL
/B	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
Th1	NULL
development	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
in	NULL
human	NULL
,	NULL
but	NULL
not	NULL
in	NULL
mouse	NULL
,	NULL
cells	NULL
.	NULL

Species-specific	NULL
activation	NULL
of	NULL
Stai4	NULL
by	NULL
IFN-	NULL
@	NULL
/B	NULL
To	NULL
explain	NULL
the	NULL
divergent	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
and	NULL
IFN-y	NULL
on	NULL
Th1	NULL
development	NULL
in	NULL
human	NULL
compared	NULL
with	NULL
mouse	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

IFN-	NULL
«	NULL
and	NULL
IFN-B	NULL
induced	NULL
a	NULL
strong	NULL
and	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statd4	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Our	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
showing	NULL
that	NULL
IFN-a	NULL
efficiently	NULL
induces	NULL
phosphorylation	NULL
of	NULL
Statd	NULL
in	NULL
mitogen-activated	NULL
PBMC	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
IL-12	NULL
and	NULL
IFN-	NULL
@	NULL
/B	NULL
activate	NULL
Stat4	NULL
,	NULL
a	NULL
protein	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
Th1	NULL
responses	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-a	NULL
treatment	NULL
does	NULL
not	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
generated	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
confirming	NULL
that	NULL
IFN-a	NULL
is	NULL
unable	NULL
to	NULL
activate	NULL
Stat4	NULL
in	NULL
a	NULL
mouse	NULL
Th1	NULL
clone	NULL
(	NULL
15	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
a	NULL
striking	NULL
and	NULL
to	NULL
date	NULL
unparalleled	NULL
species-specific	NULL
activation	NULL
of	NULL
a	NULL
STAT	NULL
factor	NULL
and	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
finding	NULL
that	NULL
IFN-	NULL
@	NULL
/B	NULL
are	NULL
powerful	NULL
inducers	NULL
of	NULL
Th1	NULL
development	NULL
only	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
Stat4	NULL
activation	NULL
for	NULL
Th1	NULL
phenotype	NULL
development	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
activation	NULL
of	NULL
Statd	NULL
in	NULL
response	NULL
to	NULL
type	NULL
I	NULL
IFNs	NULL
produced	NULL
,	NULL
for	NULL
example	NULL
,	NULL
in	NULL
the	NULL
course	NULL
of	NULL
a	NULL
viral	NULL
infection	NULL
may	NULL
induce	NULL
Th1	NULL
development	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
independently	NULL
of	NULL
IL-12	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
STAT	NULL
activation	NULL
on	NULL
differentiated	NULL
Th2	NULL
cells	NULL
The	NULL
analysis	NULL
of	NULL
Stat4-	NULL
and	NULL
Stat6-deficient	NULL
mice	NULL
has	NULL
revealed	NULL
that	NULL
activation	NULL
of	NULL
Stat4	NULL
and	NULL
Stat6	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
responses	NULL
,	NULL
respectively	NULL
(	NULL
20-24	NULL
)	NULL
,	NULL
but	NULL
is	NULL
activation	NULL
of	NULL
Stat4	NULL
and	NULL
Stat6	NULL
sufficient	NULL
to	NULL
alter	NULL
the	NULL
cytokine	NULL
secretion	NULL
pattern	NULL
characteristic	NULL
for	NULL
differentiated	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
respec-tively	NULL
?	NULL

Our	NULL
finding	NULL
that	NULL
IFN-	NULL
@	NULL
/B	NULL
induce	NULL
Stat4	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
might	NULL
suggest	NULL
that	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
Th1	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
have	NULL
similar	NULL
functional	NULL
effects	NULL
on	NULL
established	NULL
Th2	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
activation	NULL
of	NULL
Statd4	NULL
may	NULL
only	NULL
be	NULL
required	NULL
at	NULL
priming	NULL
of	NULL
T	NULL
cells	NULL
or	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
Th	NULL
subset	NULL
development	NULL
to	NULL
induce	NULL
differentiation	NULL
toward	NULL
the	NULL
Th1	NULL
phenotype	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
whether	NULL
IFN-treatment	NULL
of	NULL
established	NULL
Th2	NULL
lines	NULL
and	NULL
clones	NULL
can	NULL
,	NULL
at	NULL
least	NULL
tran-siently	NULL
,	NULL
restore	NULL
IFN-y	NULL
production	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
restimulation	NULL
of	NULL
Th2	NULL
lines	NULL
and	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-a	NULL
@	NULL
does	NULL
not	NULL
significantly	NULL
increase	NULL
IFN-y	NULL
secretion	NULL
indicates	NULL
that	NULL
activation	NULL
of	NULL
Stat4	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
to	NULL
initiate	NULL
the	NULL
genetic	NULL
program	NULL
leading	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
to	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
immune	NULL
responses	NULL
,	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
IFN-y	NULL
production	NULL
in	NULL
differentiated	NULL
Th2	NULL
cells	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
analyze	NULL
whether	NULL
activation	NULL
of	NULL
Stat4	NULL
in	NULL
Th2	NULL
cells	NULL
via	NULL
IFN-	NULL
@	NULL
/B	NULL
can	NULL
induce	NULL
other	NULL
Thl1-specific	NULL
functions	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
IL-12	NULL
responsiveness	NULL
along	NULL
Th2	NULL
differentiation	NULL
may	NULL
be	NULL
important	NULL
to	NULL
establish	NULL
a	NULL
hierarchy	NULL
between	NULL
the	NULL
Th2-	NULL
and	NULL
Th1-inducing	NULL
signals	NULL
of	NULL
IL-4	NULL
and	NULL
IL-12	NULL
,	NULL
respectively	NULL
,	NULL
but	NULL
is	NULL
not	NULL
required	NULL
to	NULL
maintain	NULL
the	NULL
polarized	NULL
phenotype	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Once	NULL
effector	NULL
T	NULL
cells	NULL
have	NULL
reached	NULL
their	NULL
developmental	NULL
end	NULL
point	NULL
,	NULL
other	NULL
factors	NULL
may	NULL
be	NULL
implicated	NULL
in	NULL
maintaining	NULL
the	NULL
polarized	NULL
phenotype	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
demonstrated	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
c-maf	NULL
and	NULL
GATA-3	NULL
transcription	NULL
factors	NULL
in	NULL
Thl1	NULL
and	NULL
Th2	NULL
cells	NULL
and	NULL
their	NULL
contributions	NULL
to	NULL
the	NULL
maintenance	NULL
of	NULL
Th	NULL
phenotypes	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
M.	NULL
Gately	NULL
for	NULL
IL-12	NULL
and	NULL
anti-IL-12	NULL
mAbs	NULL
,	NULL
U.	NULL
Gubler	NULL
for	NULL
preparing	NULL
hullL-12RB2-IgG1	NULL
expression	NULL
plasmids	NULL
,	NULL
P.	NULL
Panina-Bordignon	NULL
and	NULL
V.	NULL
Barnaba	NULL
for	NULL
providing	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
P.	NULL
Vigano	NULL
for	NULL
cord	NULL
blood	NULL
samples	NULL
,	NULL
and	NULL
E.	NULL
Bianchi	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
H.	NULL
Cherwinski	NULL
,	NULL
M.	NULL
W.	NULL
Bond	NULL
,	NULL
M.	NULL
A.	NULL
Giedlin	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Coffman	NULL
.	NULL

1986	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
murine	NULL
T	NULL
helper	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

I	NULL
.	NULL

Definition	NULL
according	NULL
to	NULL
profiles	NULL
of	NULL
lymphokine	NULL
activities	NULL
and	NULL
secreted	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

136:2348.	NULL
.	NULL

Abbas	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
K.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
A.	NULL
Sher	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
diversity	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
383:787.	NULL
.	NULL

Romagnani	NULL
,	NULL
S.	NULL
1994	NULL
.	NULL

Lymphokine	NULL
production	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
disease	NULL
states	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:227.	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

Acquisition	NULL
of	NULL
lymphokine-producing	NULL
phe-	NULL
notype	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:635.	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
M.	NULL
M.	NULL
Davis	NULL
,	NULL
and	NULL
B.	NULL
Fazekas	NULL
de	NULL
St.	NULL
Groth	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
interleukin-4	NULL
during	NULL
in	NULL
vitro	NULL
priming	NULL
determines	NULL
the	NULL
lymphokine-producing	NULL
potential	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
T	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1091.	NULL
.	NULL

Hsich	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Heimberger	NULL
,	NULL
J.	NULL
S.	NULL
Gold	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1992	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
T	NULL
helper	NULL
phenotype	NULL
development	NULL
by	NULL
interleukins	NULL
4	NULL
and	NULL
10	NULL
in	NULL
an	NULL
B	NULL
T	NULL
cell-receptor	NULL
transgenic	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
;	NULL
6065.	NULL
.	NULL

Kopf	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Le	NULL
Gros	NULL
,	NULL
M.	NULL
Bachmann	NULL
,	NULL
M.	NULL
C.	NULL
Lamers	NULL
,	NULL
H.	NULL
Bluethmann	NULL
,	NULL
and	NULL
G.	NULL
Kohler	NULL
.	NULL

1993	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
blocks	NULL
Th2	NULL
cytokine	NULL
responses	NULL
.	NULL

Nature	NULL
362:245.	NULL
.	NULL

Hsich	NULL
,	NULL
C.-S.	NULL
,	NULL
S.	NULL
E.	NULL
Macatonia	NULL
,	NULL
C.	NULL
S.	NULL
Tripp	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Development	NULL
of	NULL
T	NULL
;	NULL
;	NULL
1	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
through	NULL
IL-12	NULL
produced	NULL
by	NULL
Listeria-induced	NULL
macrophages	NULL
.	NULL

Science	NULL
260:547.	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
Gazzinelli	NULL
,	NULL
A.	NULL
Sher	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1993	NULL
.	NULL

IL-12	NULL
acts	NULL
directly	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
to	NULL
enhance	NULL
priming	NULL
for	NULL
interferon	NULL
-y	NULL
production	NULL
and	NULL
diminishes	NULL
interleukin	NULL
4	NULL
inhibition	NULL
of	NULL
such	NULL
priming	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10188	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Parronchi	NULL
,	NULL
M.	NULL
G.	NULL
Giudizi	NULL
,	NULL
M.-P.	NULL
Piccinni	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
G.	NULL
Trinchieri	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1993	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
interleukin	NULL
12	NULL
[	NULL
IL-12	NULL
]	NULL
)	NULL
induces	NULL
T	NULL
helper	NULL
1	NULL
type	NULL
(	NULL
Th1	NULL
)	NULL
-specific	NULL
immune	NULL
responses	NULL
and	NULL
inhibits	NULL
the	NULL
development	NULL
of	NULL
IL-4-producing	NULL
Th	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1199	NULL
.	NULL

Magram	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
E.	NULL
Connaughton	NULL
,	NULL
R.	NULL
R.	NULL
Warrier	NULL
,	NULL
D.	NULL
M.	NULL
Carvajal	NULL
,	NULL
C.-Y	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
Ferrante	NULL
,	NULL
C.	NULL
Stewart	NULL
,	NULL
U.	NULL
Sarimiento	NULL
,	NULL
D.	NULL
A.	NULL
Faherty	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Gately	NULL
.	NULL

1996	NULL
.	NULL

IL-12	NULL
deficient	NULL
mice	NULL
are	NULL
defective	NULL
in	NULL
IFNy	NULL
production	NULL
and	NULL
type	NULL
I	NULL
cytokine	NULL
responses	NULL
.	NULL

Immunity	NULL
4:471	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
A.	NULL
Penis	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1994.	NULL
a	NULL
novel	NULL
IL-4-induced	NULL
signal	NULL
transducing	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1350	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:1701	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
E.	NULL
F.	NULL
Petricoin	NULL
III	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O	NULL
'	NULL
Shea	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Stat4	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7307	NULL
.	NULL

Jacobson	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
S.	NULL
J.	NULL
Szabo	NULL
,	NULL
R.	NULL
N.	NULL
Weber-Nordt	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
R.	NULL
D.	NULL
Schreiber	NULL
,	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
3	NULL
and	NULL
4	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1755	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
N.	NULL
G.	NULL
Jacobson	NULL
,	NULL
A.	NULL
S.	NULL
Dighe	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1995	NULL
.	NULL

Developmental	NULL
commitment	NULL
to	NULL
the	NULL
Th2	NULL
lineage	NULL
by	NULL
extinction	NULL
of	NULL
IL-12	NULL
signaling	NULL
.	NULL

Immunity	NULL
2:665	NULL
.	NULL

Hilkins	NULL
,	NULL
C.	NULL
M.	NULL
U.	NULL
,	NULL
G.	NULL
Messer	NULL
,	NULL
K.	NULL
Tesselaar	NULL
,	NULL
A.	NULL
G.	NULL
I	NULL
van	NULL
Rietschoten	NULL
,	NULL
M.	NULL
L.	NULL
Kapsenberg	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Wierenga	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-12	NULL
signaling	NULL
in	NULL
human	NULL
allergen-specific	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4316	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

6573	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
A.	NULL
S.	NULL
Dighe	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-12R	NULL
B2	NULL
subunit	NULL
expression	NULL
in	NULL
developing	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:817	NULL
.	NULL

Rogge	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Barberis-Maino	NULL
,	NULL
M.	NULL
Biffi	NULL
,	NULL
N.	NULL
Passini	NULL
,	NULL
D.	NULL
H.	NULL
Presky	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
F.	NULL
Sinigaglia	NULL
.	NULL

1997	NULL
.	NULL

Selective	NULL
expression	NULL
of	NULL
an	NULL
interleukin-12	NULL
receptor	NULL
component	NULL
by	NULL
human	NULL
T	NULL
helper	NULL
1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:825	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.	NULL
T.	NULL
Smiley	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Minami	NULL
,	NULL
S.-L	NULL
Kashiwamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
.	NULL

Nature	NULL
380:627	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignalli	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
.	NULL

Thierfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
van	NULL
Deursen	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
C.	NULL
Grosveld	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
for	NULL
Stat4	NULL
in	NULL
interleukin-12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
382:171	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Impaired	NULL
IL-12	NULL
responses	NULL
and	NULL
enhanced	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
Stat4-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
382:174	NULL
.	NULL

Presky	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
H.	NULL
Yang	NULL
,	NULL
L.	NULL
J.	NULL
Minctti	NULL
,	NULL
A.	NULL
O.	NULL
Chua	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
C.-Y	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
K.	NULL
Gately	NULL
,	NULL
and	NULL
U.	NULL
Gubler	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
functional	NULL
interleukin-12	NULL
receptor	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
$	NULL
type	NULL
cytokine	NULL
receptor	NULL
subunits	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:14002	NULL
.	NULL

Wenner	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
M.	NULL
L.	NULL
Giler	NULL
,	NULL
S.	NULL
E.	NULL
Macatonia	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1996	NULL
.	NULL

Roles	NULL
of	NULL
IFN-y	NULL
and	NULL
IFN-a	NULL
in	NULL
IL-12	NULL
induced	NULL
T	NULL
helper	NULL
cell-1	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

1156:1442	NULL
.	NULL

Coligan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeck	NULL
,	NULL
D.	NULL
H.	NULL
Margulies	NULL
,	NULL
E.	NULL
M.	NULL
Shevach	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
.	NULL

1991	NULL
.	NULL

Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
.	NULL

Greene	NULL
&	NULL
Wiley	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Rogge	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
F.	NULL
Sinigaglia	NULL
.	NULL

1997	NULL
.	NULL

Early	NULL
events	NULL
controlling	NULL
T	NULL
helper	NULL
cell	NULL
differ-entiation	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
IL-12	NULL
receptor	NULL
.	NULL

In	NULL
ZL-72	NULL
,	NULL
Vol	NULL
.	NULL

68	NULL
.	NULL

L.	NULL
Adorini	NULL
,	NULL
ed	NULL
.	NULL

Karger	NULL
,	NULL
Milan	NULL
,	NULL
pp	NULL
.	NULL

38-53	NULL
.	NULL

Lanzavecchia	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Scheidegger	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
use	NULL
of	NULL
hybrid	NULL
hybridomas	NULL
to	NULL
target	NULL
human	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

17:105	NULL
.	NULL

Nisini	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Paroli	NULL
,	NULL
D.	NULL
Accapezzato	NULL
,	NULL
F.	NULL
Bonino	NULL
,	NULL
F.	NULL
Rosina	NULL
,	NULL
T.	NULL
Santantonio	NULL
,	NULL
F.	NULL
Sallusto	NULL
,	NULL
A.	NULL
Amoroso	NULL
,	NULL
M.	NULL
Houghton	NULL
,	NULL
and	NULL
V.	NULL
Barnaba	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
CD4*	NULL
T-cell	NULL
response	NULL
to	NULL
hepatitis	NULL
delta	NULL
virus	NULL
:	NULL
identification	NULL
of	NULL
multiple	NULL
epitopes	NULL
and	NULL
characterization	NULL
of	NULL
T-helper	NULL
cytokine	NULL
profile	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:2241	NULL
.	NULL

Bonecchi	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
Bianchi	NULL
,	NULL
P.	NULL
Panina	NULL
Bordignon	NULL
,	NULL
D.	NULL
D'Ambrosio	NULL
,	NULL
R.	NULL
Lang	NULL
,	NULL
A.	NULL
Borsatti	NULL
,	NULL
S.	NULL
Sozzani	NULL
,	NULL
P.	NULL
Allavena	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Gray	NULL
,	NULL
A.	NULL
Mantovani	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
chemokine	NULL
receptors	NULL
and	NULL
chemotactic	NULL
responsiveness	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:129	NULL
.	NULL

Sinigaglia	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
Romagnoli	NULL
,	NULL
M.	NULL
Guttinger	NULL
,	NULL
B.	NULL
Takacs	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
P.	NULL
Pink	NULL
.	NULL

1991	NULL
.	NULL

Selection	NULL
of	NULL
T	NULL
cell	NULL
epitopes	NULL
and	NULL
vaccine	NULL
engineering	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

203:370	NULL
.	NULL

Panina-Bordignon	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Mazzeo	NULL
,	NULL
P.	NULL
Di	NULL
Lucia	NULL
,	NULL
D.	NULL
D'Ambrosio	NULL
,	NULL
R.	NULL
Lang	NULL
,	NULL
L.	NULL
Fabbri	NULL
,	NULL
C.	NULL
Self	NULL
,	NULL
and	NULL
F.	NULL
Sinigaglia	NULL
.	NULL

1997	NULL
.	NULL

B2-agonists	NULL
prevent	NULL
Th1	NULL
development	NULL
by	NULL
selective	NULL
inhibition	NULL
of	NULL
IL-12	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:1513	NULL
.	NULL

Oi	NULL
,	NULL
V.	NULL
T.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1980	NULL
.	NULL

Immunoglobulin-producing	NULL
hybrid	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
Selected	NULL
Methods	NULL
in	NULL
Cellular	NULL
Immunology	NULL
.	NULL

B	NULL
.	NULL

B.	NULL
Mishell	NULL
and	NULL
S.	NULL
M.	NULL
Shiigi	NULL
,	NULL
eds	NULL
.	NULL

W.	NULL
H.	NULL
Freeman	NULL
and	NULL
Co.	NULL
,	NULL
New	NULL
York	NULL
,	NULL
pp	NULL
.	NULL

351-372	NULL
.	NULL

Reik	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
S.	NULL
L.	NULL
Maines	NULL
,	NULL
D.	NULL
E.	NULL
Ryan	NULL
,	NULL
W.	NULL
Levin	NULL
,	NULL
S.	NULL
Bandiera	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Thomas	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
simple	NULL
,	NULL
non-chromatographic	NULL
purification	NULL
procedure	NULL
for	NULL
monoclonal	NULL
an-tibodies	NULL
:	NULL
isolation	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
cytochrome	NULL
P450	NULL
isozymes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
100:123	NULL
.	NULL

Wu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
R.	NULL
R.	NULL
Warrier	NULL
,	NULL
D.	NULL
M.	NULL
Carvajal	NULL
,	NULL
A.	NULL
O.	NULL
Chua	NULL
,	NULL
L.	NULL
J.	NULL
Minetti	NULL
,	NULL
R.	NULL
Chizzonite	NULL
,	NULL
P.	NULL
K.	NULL
A.	NULL
Mongini	NULL
,	NULL
A.	NULL
S.	NULL
Stem	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
D.	NULL
H.	NULL
Presky	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Gately	NULL
.	NULL

1996	NULL
.	NULL

Biological	NULL
function	NULL
and	NULL
distribution	NULL
of	NULL
human	NULL
interleukin-12	NULL
receptor	NULL
chain	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:345	NULL
.	NULL

Murphy	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Heimberger	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1990	NULL
.	NULL

Induction	NULL
by	NULL
antigen	NULL
of	NULL
intrathymic	NULL
apoptosis	NULL
of	NULL
CD4*	NULL
CD8*	NULL
TCR	NULL
``	NULL
thymocytes	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
250	NULL
:	NULL
1720	NULL
.	NULL

Trembleau	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
Penna	NULL
,	NULL
S.	NULL
Gregori	NULL
,	NULL
M.	NULL
K.	NULL
Gately	NULL
,	NULL
and	NULL
L.	NULL
Adorini	NULL
.	NULL

1997	NULL
.	NULL

Deviation	NULL
of	NULL
pancreas-infiltrating	NULL
cells	NULL
to	NULL
Th2	NULL
by	NULL
interleukin-12	NULL
antagonist	NULL
administration	NULL
inhibits	NULL
autoimmune	NULL
diabetes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2330	NULL
.	NULL

Galbiati	NULL
,	NULL
F.	NULL
,	NULL
L.	NULL
Rogge	NULL
,	NULL
J.-C.	NULL
Guery	NULL
,	NULL
S.	NULL
Smiroldo	NULL
,	NULL
and	NULL
L.	NULL
Adorini	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
by	NULL
soluble	NULL
antigen	NULL
and	NULL
IL-12	NULL
in	NULL
vivo	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:209	NULL
.	NULL

Passini	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
D.	NULL
Larigan	NULL
,	NULL
S.	NULL
Genovese	NULL
,	NULL
E.	NULL
Appella	NULL
,	NULL
F.	NULL
Sinigaglia	NULL
,	NULL
and	NULL
L.	NULL
Rogge	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
37/40-kilodalton	NULL
autoantigen	NULL
in	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
is	NULL
the	NULL
putative	NULL
tyrosine	NULL
phosphatase	NULL
IA-2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9412	NULL
.	NULL

Haskins	NULL
,	NULL
K.	NULL
,	NULL
R.	NULL
Kubo	NULL
,	NULL
J	NULL
.	NULL

White	NULL
,	NULL
M.	NULL
Pigeon	NULL
,	NULL
J.	NULL
Kappler	NULL
,	NULL
and	NULL
P.	NULL
Marrack	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
MHC-restricted	NULL
antigen	NULL
receptor	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

I	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

157:1149	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
F.	NULL
Gerosa	NULL
,	NULL
M.	NULL
G.	NULL
Giudizi	NULL
,	NULL
R.	NULL
Biagiotti	NULL
,	NULL
P.	NULL
Parronchi	NULL
,	NULL
M.-P.	NULL
Piccinni	NULL
,	NULL
S.	NULL
Sampognaro	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
S.	NULL
Romagnani	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
stable	NULL
priming	NULL
for	NULL
interferon	NULL
-y	NULL
(	NULL
IFN-y	NULL
)	NULL
production	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
and	NULL
transient	NULL
IFN-y	NULL
production	NULL
in	NULL
established	NULL
Th2	NULL
cell	NULL
clones	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:1273	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1996	NULL
.	NULL

Cooperative	NULL
DNA	NULL
binding	NULL
and	NULL
sequence-selective	NULL
recognition	NULL
conferred	NULL
by	NULL
the	NULL
STAT	NULL
amino-terminal	NULL
domain	NULL
.	NULL

Nature	NULL
273:794	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6574	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Brinkmann	NULL
,	NULL
V.	NULL
,	NULL
T.	NULL
Geiger	NULL
,	NULL
S.	NULL
Alkan	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
Heusser	NULL
.	NULL

1993	NULL
.	NULL

Interferon	NULL
a	NULL
increases	NULL
the	NULL
frequency	NULL
of	NULL
interferon	NULL
y-producing	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1655	NULL
.	NULL

Parronchi	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Mohapatra	NULL
,	NULL
S.	NULL
Sampognaro	NULL
,	NULL
L.	NULL
Giannarini	NULL
,	NULL
U.	NULL
Wahn	NULL
,	NULL
P.	NULL
Chong	NULL
,	NULL
S.	NULL
Mohapatra	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
H.	NULL
Renz	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
interfer-on-	NULL
@	NULL
on	NULL
cytokine	NULL
profile	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
repertoire	NULL
and	NULL
peptide	NULL
reactivity	NULL
of	NULL
human	NULL
allergen-specific	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:697	NULL
.	NULL

Schmitt	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Hochn	NULL
,	NULL
C.	NULL
Huels	NULL
,	NULL
S.	NULL
Goedert	NULL
,	NULL
N.	NULL
Palm	NULL
,	NULL
E.	NULL
Riide	NULL
,	NULL
and	NULL
T.	NULL
Germann	NULL
.	NULL

1994	NULL
.	NULL

T	NULL
helper	NULL
type	NULL
1	NULL
development	NULL
of	NULL
naive	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
requires	NULL
the	NULL
coordinate	NULL
action	NULL
of	NULL
interleukin-12	NULL
and	NULL
interferon-y	NULL
and	NULL
is	NULL
inhibited	NULL
by	NULL
transforming	NULL
growth	NULL
factor-B	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:793	NULL
.	NULL

Bradley	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
D.	NULL
K.	NULL
Dalton	NULL
,	NULL
and	NULL
M.	NULL
Croft	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
direct	NULL
role	NULL
for	NULL
IFN-y	NULL
in	NULL
regulation	NULL
of	NULL
Th1	NULL
cell	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:1350	NULL
.	NULL

Chakrabarti	NULL
,	NULL
D.	NULL
,	NULL
B.	NULL
Hultgren	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Stewart	NULL
.	NULL

1996	NULL
.	NULL

IFN-	NULL
@	NULL
induces	NULL
autoimmune	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
intracellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
B7.2	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:522	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

STAT	NULL
ACTIVATION	NULL
IN	NULL
DEVELOPING	NULL
AND	NULL
DIFFERENTIATED	NULL
Th	NULL
CELLS	NULL
Trinchieri	NULL
,	NULL
G.	NULL
1995	NULL
.	NULL

Interleukin-12	NULL
:	NULL
A	NULL
proinflammatory	NULL
cytokine	NULL
with	NULL
immuno-regulatory	NULL
functions	NULL
that	NULL
bridge	NULL
innate	NULL
resistance	NULL
and	NULL
antigen-specific	NULL
adaptive	NULL
immunity	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
13:251	NULL
.	NULL

Giller	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
J.	NULL
D.	NULL
Gorham	NULL
,	NULL
C.-S.	NULL
Hsich	NULL
,	NULL
A.	NULL
J.	NULL
Mackey	NULL
,	NULL
R.	NULL
G.	NULL
Steen	NULL
,	NULL
W.	NULL
F.	NULL
Dietrich	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1996	NULL
.	NULL

Genetic	NULL
Susceptibility	NULL
to	NULL
Leishmania	NULL
:	NULL
TL-12	NULL
responsiveness	NULL
in	NULL
THI1	NULL
cell	NULL
development	NULL
.	NULL

Science	NULL
277:984	NULL
.	NULL

Cho	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
C.	NULL
Sudarshan	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
D.	NULL
Finbloom	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
Stat4	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
ligand-induced	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
;	NULL
4781	NULL
.	NULL

Ho	NULL
,	NULL
L-C.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proto-oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
85:973	NULL
.	NULL

Zheng	NULL
,	NULL
W.-p.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89:587	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

